Giovanni Camussi Selected Research

nephrin

9/2009	Effect of the monocyte chemoattractant protein-1/CC chemokine receptor 2 system on nephrin expression in streptozotocin-treated mice and human cultured podocytes.
1/2009	Nephrin and endothelial injury.
8/2008	Hyperglycemia induces apoptosis of human pancreatic islet endothelial cells: effects of pravastatin on the Akt survival pathway.
5/2008	Preeclamptic sera induce nephrin shedding from podocytes through endothelin-1 release by endothelial glomerular cells.
1/2008	Circulating plasma factors induce tubular and glomerular alterations in septic burns patients.
2/2007	HIV-1 Tat reduces nephrin in human podocytes: a potential mechanism for enhanced glomerular permeability in HIV-associated nephropathy.
12/2006	Calpain activation and secretion promote glomerular injury in experimental glomerulonephritis: evidence from calpastatin-transgenic mice.
7/2005	Direct effect of plasma permeability factors from patients with idiopatic FSGS on nephrin and podocin expression in human podocytes.
2/2005	Insight on the pathogenesis of diabetic nephropathy from the study of podocyte and mesangial cell biology.
4/2003	Nephrin expression is reduced in human diabetic nephropathy: evidence for a distinct role for glycated albumin and angiotensin II.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Giovanni Camussi Research Topics

Disease

42	Neoplasms (Cancer) 10/2020 - 06/2003
17	Inflammation (Inflammations) 01/2022 - 08/2002
13	Proteinuria 01/2020 - 10/2002
10	Reperfusion Injury 01/2022 - 08/2003
9	Hypoxia (Hypoxemia) 11/2019 - 01/2012
9	Acute Kidney Injury (Acute Renal Failure) 05/2019 - 01/2008
8	Ischemia 01/2022 - 01/2011
8	Fibrosis (Cirrhosis) 01/2022 - 11/2016
8	Diabetic Nephropathies (Diabetic Nephropathy) 01/2019 - 04/2003
7	Necrosis 01/2020 - 10/2002
7	Renal Cell Carcinoma (Grawitz Tumor) 01/2019 - 08/2002
6	Neoplasm Metastasis (Metastasis) 10/2020 - 12/2009
6	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 08/2014 - 04/2003
5	Glomerulonephritis 01/2021 - 06/2005
5	Infections 03/2010 - 10/2002
4	Chronic Renal Insufficiency 01/2022 - 01/2019
4	Kidney Neoplasms (Kidney Cancer) 01/2019 - 12/2011
4	Sepsis (Septicemia) 01/2018 - 10/2002
4	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2017 - 04/2003
4	Kaposi Sarcoma (Kaposi's Sarcoma) 03/2010 - 07/2002
4	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 02/2009 - 09/2006
3	Membranous Glomerulonephritis (Membranous Nephropathy) 10/2020 - 02/2003
3	Rhabdomyolysis 11/2016 - 05/2013
2	Acute Coronary Syndrome 09/2021 - 01/2021
2	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2020 - 01/2019
2	Hepatocellular Carcinoma (Hepatoma) 06/2019 - 09/2012
2	Hyperglycemia 01/2019 - 08/2008
2	Disease Progression 12/2018 - 01/2007
2	Ovarian Neoplasms (Ovarian Cancer) 01/2018 - 01/2016
2	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 01/2017 - 07/2005
2	Pathologic Processes 11/2016 - 01/2016
2	Carcinogenesis 01/2014 - 02/2004
2	Burns 12/2012 - 01/2008

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 01/2020 - 07/2002
16	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2011
11	Biomarkers (Surrogate Marker)IBA 01/2021 - 12/2014
10	nephrinIBA 09/2009 - 04/2003
8	CytokinesIBA 01/2022 - 07/2003
8	Biological ProductsIBA 12/2020 - 10/2008
8	matrigelIBA 01/2019 - 09/2003
6	Messenger RNA (mRNA)IBA 01/2021 - 02/2006
6	Platelet Activating FactorIBA 10/2007 - 08/2002
4	CateninsIBA 10/2021 - 05/2005
4	Complement System Proteins (Complement)IBA 01/2021 - 06/2003
4	Pharmaceutical PreparationsIBA 01/2021 - 11/2008
4	Interleukin-3 (Interleukin 3)IBA 10/2020 - 07/2002
4	Urea (Carbamide)FDA LinkGeneric 01/2020 - 01/2008
4	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 02/2005
4	EnzymesIBA 01/2018 - 09/2003
4	AntigensIBA 08/2014 - 02/2006
4	Phospholipids (Phosphatides)FDA LinkGeneric 02/2006 - 08/2002
3	Therapeutic UsesIBA 01/2022 - 01/2019
3	salicylhydroxamic acid (SHAM)IBA 09/2021 - 05/2011
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 07/2003
3	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2019
3	erucylphosphocholineIBA 01/2021 - 10/2004
3	Interleukin-6 (Interleukin 6)IBA 01/2021 - 07/2003
3	CreatinineIBA 01/2020 - 01/2008
3	Streptozocin (Streptozotocin)FDA Link 01/2019 - 01/2018
3	SteroidsIBA 01/2017 - 07/2005
3	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 02/2004
3	Glycerol (Glycerine)FDA LinkGeneric 11/2016 - 10/2010
3	Cadherins (E-Cadherin)IBA 03/2016 - 05/2005
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2015 - 01/2009
3	Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA 03/2010 - 04/2006
3	Angiotensin IIIBA 01/2009 - 04/2003
3	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 08/2008 - 07/2002
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 01/2011
2	Transforming Growth Factor beta (TGF-beta)IBA 01/2021 - 03/2004
2	AutoantibodiesIBA 10/2020 - 06/2003
2	aristolochic acid I (aristolochic acid)IBA 01/2020 - 01/2018
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 11/2019 - 05/2015
2	CaspasesIBA 01/2018 - 01/2015
2	ImmunosorbentsIBA 01/2018 - 08/2014
2	Adenosine Triphosphate (ATP)IBA 01/2018 - 08/2014
2	Erythropoietin FDA Link 11/2016 - 07/2013
2	LipopolysaccharidesIBA 04/2016 - 01/2013
2	Tumor Biomarkers (Tumor Markers)IBA 03/2016 - 01/2014
2	NestinIBA 03/2016 - 10/2008
2	Nucleic AcidsIBA 01/2016 - 01/2016
2	Transcription Factors (Transcription Factor)IBA 01/2016 - 02/2004
2	Conditioned Culture MediaIBA 04/2015 - 10/2009
2	Caspase 3 (Caspase-3)IBA 08/2014 - 10/2002
2	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 08/2014 - 08/2010
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 05/2013 - 12/2006
2	Interleukin-15 (Interleukin 15)IBA 02/2013 - 12/2011
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 10/2012 - 01/2011
2	Ribonucleases (Ribonuclease)IBA 09/2012 - 05/2011
2	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2010 - 12/2008
2	Immunoglobulin A (IgA)IBA 03/2010 - 02/2003

Therapy/Procedure

19	Therapeutics 10/2020 - 01/2006
5	Transplantation 12/2019 - 10/2008
3	Intravenous Injections 10/2020 - 10/2010
3	Liver Transplantation 01/2020 - 01/2013
3	Immunotherapy 01/2016 - 12/2011
2	Percutaneous Coronary Intervention 09/2021 - 01/2021
2	Subcutaneous Injections 01/2020 - 03/2013
2	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2019 - 11/2016
2	Drug Therapy (Chemotherapy) 01/2015 - 03/2010
2	Kidney Transplantation 01/2015 - 02/2013